Literature DB >> 16876392

Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.

Inmaculada Fuertes1, Antonia Miranda, Mónica Millán, Isidoro Caraballo.   

Abstract

The principles of percolation theory were applied to design controlled release matrix tablets containing acyclovir. This statistical theory studies disordered or chaotic systems where the components are randomly distributed in a lattice. The application of this theory to study the release and hydration rate of hydrophilic matrices allows to explain the changes in release and hydration kinetics of swellable matrix type controlled delivery systems. The objective of the present paper is to estimate the percolation threshold of HPMC K4M in matrices of acyclovir and to apply the obtained result to the design of hydrophilic matrices for the controlled delivery of this drug. Matrix tablets have been prepared using acyclovir as drug and HPMC K4M as matrix forming material, employing five different excipient/drug percentages. Dissolution studies were carried out using the paddle method. Water uptake measurements were performed using a modified Enslin apparatus. In order to estimate the percolation threshold, the behaviour of the kinetic parameters with respect to the excipient volumetric fraction at time zero plus initial porosity was studied. According to percolation theory, the critical points observed in dissolution and water uptake studies can be attributed to the excipient percolation threshold. This threshold was situated between between 20.76% and 26.41% v/v of excipient plus initial porosity. The knowledge of the percolation threshold of the components of the matrix formulations contributes to improve their design. First, reducing the time to market and second, increasing their robustness when they are prepared at Industrial scale, avoiding the formulation in the nearby of the percolation threshold.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876392     DOI: 10.1016/j.ejpb.2006.05.009

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  8 in total

1.  Mucoadhesive microspheres for gastroretentive delivery of acyclovir: in vitro and in vivo evaluation.

Authors:  Sumeet Dhaliwal; Subheet Jain; Hardevinder P Singh; A K Tiwary
Journal:  AAPS J       Date:  2008-06-04       Impact factor: 4.009

2.  Polymer percolation threshold in HPMC extended release formulation of carbamazepine and verapamil HCl.

Authors:  Tamara Gonçalves-Araújo; Ali R Rajabi-Siahboomi; Isidoro Caraballo
Journal:  AAPS PharmSciTech       Date:  2010-03-30       Impact factor: 3.246

3.  Polymer Percolation Threshold in Multi-Component HPMC Matrices Tablets.

Authors:  Maryam Maghsoodi; Leila Barghi
Journal:  Adv Pharm Bull       Date:  2011-07-20

4.  The impact of dose and solubility of additives on the release from HPMC matrix tablets--identifying critical conditions.

Authors:  Farhad Tajarobi; Susanna Abrahmsén-Alami; Magnus Hansen; Anette Larsson
Journal:  Pharm Res       Date:  2009-03-12       Impact factor: 4.200

5.  Estimation of the percolation thresholds in lobenzarit disodium native dextran matrix tablets.

Authors:  Eddy Castellanos Gil; Antonio Iraizoz Colarte; Bernard Bataille; Isidoro Caraballo
Journal:  AAPS PharmSciTech       Date:  2007-12-28       Impact factor: 3.246

6.  Formulation and optimization of mucoadhesive nanodrug delivery system of acyclovir.

Authors:  Uv Bhosale; Devi V Kusum; N Jain
Journal:  J Young Pharm       Date:  2011-10

7.  Effect of Hydrophilic Polymers on the Release Rate and Pharmacokinetics of Acyclovir Tablets Obtained by Wet Granulation: In Vitro and In Vivo Assays.

Authors:  D Nagasamy Venkatesh; Subramanianainar N Meyyanathan; Andjelka Kovacevic; Aleksandra Zielińska; Joel Fonseca; Piotr Eder; Agnieszka Dobrowolska; Eliana B Souto
Journal:  Molecules       Date:  2022-10-01       Impact factor: 4.927

8.  Development and characterization of gastroretentive sustained-release formulation by combination of swelling and mucoadhesive approach: a mechanistic study.

Authors:  R Sankar; Subheet Kumar Jain
Journal:  Drug Des Devel Ther       Date:  2013-12-05       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.